Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Cristina Carrera Ana Arance Francisco Aya Aranzazu Fernandez-Martinez |
| Publication date | April 26, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |